Literature DB >> 29743586

HLA alleles in British Caucasians with mucous membrane pemphigoid.

F Hübner1, J Setterfield2, A Recke1, D Zillikens1, E Schmidt1,3, J Dart4, S Ibrahim5.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29743586      PMCID： PMC6137197          DOI： 10.1038/s41433-018-0092-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

Review 1.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

2.  Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.

Authors:  J Setterfield; J Theron; R W Vaughan; K I Welsh; E Mallon; F Wojnarowska; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

Review 3.  Cicatricial pemphigoid and dry eye.

Authors:  John Dart
Journal:  Semin Ophthalmol       Date:  2005 Apr-Jun       Impact factor: 1.975

4.  Mucous Membrane Pemphigoid with Ocular Involvement: The Clinical Phenotype and Its Relationship to Direct Immunofluorescence Findings.

Authors:  Hon Shing Ong; Jane F Setterfield; Darwin C Minassian; John K Dart
Journal:  Ophthalmology       Date:  2017-12-06       Impact factor: 12.079
  4 in total
  3 in total

Review 1.  The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid.

Authors:  Mayumi Kamaguchi; Hiroaki Iwata
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

Review 2.  Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes.

Authors:  A Razzaque Ahmed; Sarah Anwar; Pedro A Reche
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

3.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.